SPDL1 and hepatocellular carcinoma: In a study conducted in early HCC patients who underwent surgical liver resection, the persistence after treatment of sPD-L1 indicated a poor outcome, suggesting the possibility to apply sPD-L1 analysis for identifying patients eligible for adjuvant immunotherapy [37].